Artivion SVP trades shares, receives stock grant

Artivion, Inc. senior vice president and general counsel Jean F. Holloway reported both stock sales and an equity award in company shares.

Rhea-AI Filing Summary

Artivion, Inc. senior vice president and general counsel Jean F. Holloway reported both stock sales and an equity award in company shares. On February 23–24, 2026, she sold a total of 4,747 shares of common stock at prices of $37.588 and $35.693 per share.

Footnotes state these sales were automatically executed to cover tax withholding owed upon vesting of performance and restricted stock units, and are not discretionary trades. She also received a grant of 20,085 shares of restricted stock at no cost, which vest in three equal annual installments starting on the first anniversary of the grant date.

Insider Trade Summary

Net Seller: 4,747 shares

Net Sell 3 txns

Insider Holloway Jean F

Role SVP, General Counsel

Sold 4,747 shs ($175K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,668	$35.693	$60K
Grant/Award	Common Stock	20,085	$0.00	$0.00
Sale	Common Stock	3,079	$37.588	$116K

Holdings After Transaction: Common Stock — 172,288 shares (Direct)

Footnotes (3)

1. F1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
2. F2. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
3. F3. Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AORT executive Jean F. Holloway report?

Jean F. Holloway reported selling 4,747 shares of Artivion common stock and receiving a grant of 20,085 restricted shares. The sales were linked to tax withholding on vested equity awards, while the grant forms part of her long-term equity compensation package.

Were Jean F. Holloway’s AORT share sales discretionary trades?

No, the filing states the sales were not discretionary. Shares were sold automatically in “sell to cover” transactions to pay tax withholding on vesting performance and restricted stock units, rather than elective open-market selling for investment or portfolio management purposes.

How many Artivion (AORT) shares did Jean F. Holloway sell and at what prices?

She sold 3,079 shares at $37.588 per share on February 23, 2026 and 1,668 shares at $35.693 per share on February 24, 2026. These sales were executed to satisfy tax withholding obligations related to vesting equity awards.

What equity award did Jean F. Holloway receive from Artivion (AORT)?

She received a grant of 20,085 shares of restricted stock at a price of $0.00 per share. According to the filing, these restricted shares vest 33 1/3% per year over three years, beginning on the first anniversary of the grant date.

How do these transactions affect Jean F. Holloway’s Artivion share holdings?

After the February 23, 2026 tax sale, she held 153,871 shares, and after the February 24, 2026 sale she held 152,203 shares. Following the 20,085-share restricted stock grant, her direct holdings increased to 172,288 shares of Artivion common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 05:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holloway Jean F

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		S		3,079(1)	D	$37.588	153,871	D
Common Stock	02/24/2026		S		1,668(2)	D	$35.693	152,203	D
Common Stock	02/24/2026		A		20,085(3)	A	$0	172,288	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

2. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

3. Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Jean F Holloway	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.